Cargando…

Development of a cuproptosis-related signature for prognosis prediction in lung adenocarcinoma based on WGCNA

BACKGROUND: Cuproptosis is a novel mitochondrial respiration-dependent cell death mechanism induced by copper that can kill cancer cells via copper carriers in cancer therapy. However, the clinical significance and prognostic value of cuproptosis in lung adenocarcinoma (LUAD) remains unclear. METHOD...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ling, Xiaodong, Zhang, Luquan, Fang, Chengyuan, Liang, Hao, Zhu, Jinhong, Ma, Jianqun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10183398/ https://www.ncbi.nlm.nih.gov/pubmed/37197625 http://dx.doi.org/10.21037/tlcr-23-157

Ejemplares similares

Cuproptosis-related gene signatures for predicting prognosis of lung adenocarcinoma
por: Ye, Wei, et al.
Publicado: (2022)

Identification of cuproptosis-related gene signature to predict prognosis in lung adenocarcinoma
por: Lv, Yanju, et al.
Publicado: (2022)

Identification and validation of an eight-lncRNA signature that predicts prognosis in patients with esophageal squamous cell carcinoma
por: Zhang, Jinfeng, et al.
Publicado: (2022)

Identification of 9 Gene Signatures by WGCNA to Predict Prognosis for Colon Adenocarcinoma
por: Yang, Mian, et al.
Publicado: (2022)

Cuproptosis-related signature predicts prognosis, immunotherapy efficacy, and chemotherapy sensitivity in lung adenocarcinoma
por: Wu, Gujie, et al.
Publicado: (2023)

Cuproptosis and Immune-Related Gene Signature Predicts Immunotherapy Response and Prognosis in Lung Adenocarcinoma
por: Sun, Zihao, et al.
Publicado: (2023)

A novel defined cuproptosis-related gene signature for predicting the prognosis of lung adenocarcinoma
por: Zhang, Huizhe, et al.
Publicado: (2022)

A cuproptosis-related lncRNA signature for predicting prognosis and immunotherapy response of lung adenocarcinoma
por: Yu, Sheng, et al.
Publicado: (2023)

The signature of cuproptosis-related immune genes predicts the tumor microenvironment and prognosis of prostate adenocarcinoma
por: Yao, Kai, et al.
Publicado: (2023)

Development of immune gene pair-based signature predictive of prognosis and immunotherapy in esophageal cancer
por: Cao, Kui, et al.
Publicado: (2021)

A cuproptosis-related long non-coding RNA signature to predict the prognosis and immune microenvironment characterization for lung adenocarcinoma
por: Ma, Shouzheng, et al.
Publicado: (2022)

Cuproptosis-related lncRNA signatures: Predicting prognosis and evaluating the tumor immune microenvironment in lung adenocarcinoma
por: Zhang, Pengpeng, et al.
Publicado: (2023)

A novel cuproptosis-related lncRNA signature to predict prognosis and immune landscape of lung adenocarcinoma
por: Wang, Xinyi, et al.
Publicado: (2023)

A cuproptosis-related lncRNA signature to predict prognosis and immune microenvironment of colon adenocarcinoma
por: Li, Dongming, et al.
Publicado: (2023)

Cuproptosis-related gene signature correlates with the tumor immune features and predicts the prognosis of early-stage lung adenocarcinoma patients
por: Tang, Yu, et al.
Publicado: (2022)

A novel defined cuproptosis-related gene signature for predicting the prognosis of colon adenocarcinoma
por: Luo, Bixian, et al.
Publicado: (2022)

Identification of cuproptosis and immune-related gene prognostic signature in lung adenocarcinoma
por: Zhang, Wentao, et al.
Publicado: (2023)

A cuproptosis-related signature for predicting the prognosis of gastric cancer
por: He, Chunmei, et al.
Publicado: (2023)

Pan-cancer analysis of UBE2T with a focus on prognostic and immunological roles in lung adenocarcinoma
por: Cao, Kui, et al.
Publicado: (2022)

Cuproptosis-related lncRNA predict prognosis and immune response of lung adenocarcinoma
por: Wang, Fangwei, et al.
Publicado: (2022)

Cuproptosis predicts the risk and clinical outcomes of lung adenocarcinoma
por: Hu, Qin, et al.
Publicado: (2022)

A Prognostic Cuproptosis-Related LncRNA Signature for Colon Adenocarcinoma
por: Zhong, Like, et al.
Publicado: (2023)

Development and validation of an RBP gene signature for prognosis prediction in colorectal cancer based on WGCNA
por: Cao, Lu, et al.
Publicado: (2023)

A cuproptosis-related lncRNAs risk model to predict prognosis and guide immunotherapy for lung adenocarcinoma
por: Li, Qixuan, et al.
Publicado: (2023)

Comprehensive analysis of the cuproptosis-related model to predict prognosis and indicate tumor immune infiltration in lung adenocarcinoma
por: Wu, Minle, et al.
Publicado: (2022)

Establishment of a prognostic signature for lung adenocarcinoma using cuproptosis-related lncRNAs
por: Yalimaimaiti, Saiyidan, et al.
Publicado: (2023)

A novel defined risk signature of cuproptosis-related long non-coding RNA for predicting prognosis, immune infiltration, and immunotherapy response in lung adenocarcinoma
por: Ma, Chao, et al.
Publicado: (2023)

Deep learning reveals cuproptosis features assist in predict prognosis and guide immunotherapy in lung adenocarcinoma
por: Li, Gang, et al.
Publicado: (2022)

The cuproptosis-related signature predicts prognosis and indicates immune microenvironment in breast cancer
por: Li, Jia, et al.
Publicado: (2022)

LncRNAs signatures associated with cuproptosis predict the prognosis of endometrial cancer
por: Qi, Shiyuan, et al.
Publicado: (2023)

Cuproptosis-related prognostic signatures predict the prognosis and immunotherapy in HCC patients
por: Peng, Hong, et al.
Publicado: (2023)

A novel cuproptosis-related gene signature to predict prognosis in Glioma
por: Zhang, Mengyang, et al.
Publicado: (2023)

Cross-talk between cuproptosis and ferroptosis regulators defines the tumor microenvironment for the prediction of prognosis and therapies in lung adenocarcinoma
por: Shen, Yefeng, et al.
Publicado: (2023)

Cuproptosis-Related Signature Predicts the Prognosis, Tumor Microenvironment, and Drug Sensitivity of Hepatocellular Carcinoma
por: Qi, Xiangjun, et al.
Publicado: (2022)

Improvement of ACK1-targeted therapy efficacy in lung adenocarcinoma using chloroquine or bafilomycin A1
por: Zhu, Jinhong, et al.
Publicado: (2023)

Cuproptosis Depicts Immunophenotype and Predicts Immunotherapy Response in Lung Adenocarcinoma
por: Zhou, Wolong, et al.
Publicado: (2023)

A novel cuproptosis-related gene signature for predicting prognosis in cervical cancer
por: Lei, Lei, et al.
Publicado: (2022)

Identification of cuproptosis-associated IncRNAs signature and establishment of a novel nomogram for prognosis of stomach adenocarcinoma
por: Yu, Wei, et al.
Publicado: (2022)

Development and Validation of a Seven-Gene Signature for Predicting the Prognosis of Lung Adenocarcinoma
por: Zhang, Yingqing, et al.
Publicado: (2020)

Cuproptosis-related LncRNAs signature as biomarker of prognosis and immune infiltration in pancreatic cancer
por: Chen, Hui, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ic9p5omji8ipl9kq2p1rk6a091